UNSPSC 51271601: Cinchocaine or dibucaine

This classification denotes an anesthetic agent with the molecular formula C20H29N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6JW2TJG99, chemically known as 4-quinolinecarboxamide, 2-butoxy-n-(2-(diethylamino)ethyl)- but generally known as cinchocaine, which bears US NIH Compound Identifier 3025. European Medicines Agency schedules Cinchocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06287MIG. The term CINCHOCAINE is an International Non-Proprietary Name.

UNSPSC 51271601 Cinchocaine or dibucaine is a Commodity code for local anesthetic pharmaceutical compounds used in medical and dental applications. State and local governments procure these products primarily through health departments, public health clinics, correctional facilities, and emergency medical services for use in wound care, minor surgical procedures, dental anesthesia, and pain management in clinical settings. The products are typically purchased as injectable solutions or topical formulations in bulk quantities through standing orders or as-needed procurement against master agreements with pharmaceutical distributors.

The recent state and local contract opportunities block contains no posted solicitations under this code. Activity in this Commodity tier is sparse or inactive in the current public procurement pipeline.